eGFR calculated from cystatin C: implications for dosing of direct oral anticoagulants-Reference-Cited by-同舟云学术

eGFR calculated from cystatin C: implications for dosing of direct oral anticoagulants

Published:2024-07-19 Issue: Volume: Page:
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Shin Jung-Im¹^ORCID,Ballew Shoshana²³,Bosi Alessandro⁴,Hjemdahl Paul⁵^ORCID,Grams Morgan E¹²⁶,Coresh Josef¹²³,Inker Lesley A⁷,Carrero Juan-Jesus⁴⁸^ORCID

Affiliation:

1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD , USA

2. Department of Population Health, New York University Grossman School of Medicine , New York, NY , USA

3. Optimal Aging Institute, New York University Grossman School of Medicine , New York, NY , USA

4. Department of Medical Epidemiology and Biostatistics, Karolinska Institute , Stockholm , Sweden

5. Clinical Epidemiology Unit/Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden

6. Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine , New York, NY , USA

7. Division of Nephrology, Department of Internal Medicine, Tufts Medical Center , Boston, MA , USA

8. Division of Nephrology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet , Stockholm , Sweden

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Swedish Heart and Lung Foundation

ALF Medicine

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfae171/58859839/gfae171.pdf

Reference10 articles.

1. New creatinine- and cystatin C-based equations to estimate GFR without race;Inker;N Engl J Med,2021

2. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group;Kidney Int Suppl,2013

3. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis;Caso;Heart,2023

4. The Stockholm CREAtinine Measurements (SCREAM) project: fostering improvements in chronic kidney disease care;Carrero;J Intern Med,2022

5. Summary of Product Characteristics;Eliquis